Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer.

About Us

Our News

Keep upto date with our regular news and updated on all our research and product launches

Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...

Publication of ASPIRE Clinical Trial Results

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...

Cell Medica Appoints Julia P. Gregory as Non-Executive Director and Audit Chair

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...

Cell and Gene Therapy Catapult manufacturing centre officially opens

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...

Cell Medica announces the appointment of Luis Borges, PhD, as Chief Scientific Officer

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...

Cell Medica announces appointment of industry leader Dr Annalisa Jenkins as Chair

Cell Medica develops, manufactures and markets personalized cellular immunotherapeutics for cancer.

Read More...
More News Posts